Background: The risk of postoperative pyoderma gangrenosum (PG) in patients with a known history of PG is unknown.
P yoderma gangrenosum (PG) is a neutrophilic process characterized by pathergy. 1 Postoperative PG as a primary phenomenon has been characterized in the literature as being less likely associated with systemic diseases, with onset usually in the first week after the procedure has been performed. 2, 3 Little is known about the risk for postoperative PG or recurrence or exacerbation of PG in patients with a known history of PG. Quantifying overall and procedure-specific risks for postoperative recurrence or exacerbation of PG may affect medical decision making for patients with a known history of PG, such as initiating prophylactic immunosuppression before procedures or avoiding and/or adjusting the timing of elective procedures. In this study, we aimed to evaluate the risk for recurrence or exacerbation of PG after different types of procedures in patients with a known history of PG.
METHODS
We searched the Research Patient Data Repository, a database of the medical records of all patients seen at Partners Healthcare, for patients with PG who underwent procedures at the Brigham and Women's Hospital and Massachusetts General Hospital from 2000 to 2015. The search was performed using the International Classification of Diseases, Ninth Revision, Clinical Modification code for pyoderma gangrenosum (686.01). The medical records for returned cases were individually reviewed to confirm a diagnosis of PG by using previously described major and minor criteria suggestive of a diagnosis of PG. 4 Relevant information regarding the original PG and all subsequent surgical procedures underwent by the patient since the original diagnosis of PG were extracted, with the primary outcome being exacerbation or recurrence of PG within 30 days of the procedure. All data were managed by using Research Electronic Data Capture. 5 Patients without a diagnosis of PG, subsequent procedures, or adequate clinical documentation were excluded.
The types of procedures examined were (1) skin biopsies; (2) 
RESULTS
Of the 530 patients identified by using International Classification of Diseases, Ninth Revision, Clinical Modification codes for PG, 166 met the inclusion criteria with a confirmed diagnosis of PG and subsequent procedures. Each patient underwent a median of 2 (interquartile range, 1-4) additional surgical procedures, for a total of 601 surgical procedures evaluated. The mean age was 52.8 years, and 80.1% of the patients (n = 133) were women. The most common PG-related comorbidity was inflammatory bowel disease (44.6% [n = 74]), and the most common location of original PG was the lower extremities (57.8% [n = 96]) (Table I) .
We found a total of 33 cases of postsurgical exacerbation or recurrence of PG occurring in 25 patients, accounting for a recurrence rate of 5.5% by procedure (33 of 601) (Table II) and 15.1% by patient (25 of 166). Univariable analysis at the procedure level demonstrated that the rate of exacerbation or recurrence was significantly associated with procedure type (P = .022) and having PG chronically present at time of the procedure (P = .041) ( Table II) . Age of 60 years or older at time of the surgical procedure, sex, comorbidities, location of the original PG or surgical procedure, location of surgical procedure being at the same site as the original PG, new/expanding/multifocal PG at time of the procedure, and chronic or prophylactic immunosuppression were not statistically significant predictors of PG recurrence. Furthermore, time elapsed since the original PG and the additional
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Multivariable regression modeled exacerbation/ recurrence as a function of age at time of the surgical procedure, chronically present PG, and procedure types (P \.10). Age of 60 years or older at time of the surgical procedure was associated with increased odds of PG recurrence and was of marginal statistical significance, with an aOR of 2. (Table III) . PG chronically present at time of the surgical procedure had an aOR of 4.58 (95% CI, 1.72-12.22).
In a sensitivity analysis, we examined the relationship between patient-level characteristics at time of the first surgical procedure with recurrence or exacerbation (n = 166); age, sex, comorbidities, location of PG, multifocal ulcer, and chronic immunosuppression were not significantly associated with recurrence in this study.
DISCUSSION
Although pathergy associated with PG is a well-known phenomenon, our study found that the risk for postsurgical recurrence or exacerbation of PG in patients with a known history of PG is relatively low at 5.5% (33 of 60 surgical procedures). However, recurrence or exacerbation occurred in 15.1% of our patients (25 of 166), suggesting that the per-patient risk for experiencing a recurrence of postsurgical recurrence or exacerbation of PG is clinically relevant. Independent risk factors influencing recurrence or exacerbation of PG after the procedure were procedure type and having chronic PG at the time of procedure. More invasive procedures such as small and large open surgical procedures, Mohs micrographic surgery/ skin excision, and debridement were more likely to be associated with PG recurrence. This study builds on the existing literature in PG by quantifying the risk for postsurgical recurrence or exacerbation of PG in patients with a known history of PG, which will help inform patients and physicians when assessing the risk associated with surgical procedures. In general, the greater the amount of tissue manipulation, the higher the likelihood of subsequent PG. This concept has face validity and is consistent with current understanding of the pathophysiology of PG and pathergy, which is thought to involve dysfunction and upregulation of neutrophil activities. 6, 7 Invasive surgical procedures are likely associated with more tissue manipulation, inflammation, and surgical stress. Time elapsed between the original PG diagnosis and surgery did not significantly influence recurrence risk, suggesting that the neutrophilic dysfunction of PG may be intrinsic to the host, with limited change over time.
Chronic or prophylactic immunosuppression leading up to surgery did not significantly influence recurrence risk in our study. However, this finding may reflect confounding by indication in that the use For the results section, the mean age was 52.8 years (SD, 17.6), with a median of 2 additional surgical procedures (interquartile range, 1-4). PG, Pyoderma gangrenosum; PVD, peripheral vascular disease; SD, standard deviation.
Abbreviations used:
aOR: adjusted odds ratio CI: confidence interval PG:
pyoderma gangrenosum of chronic immunosuppression may be correlated with baseline severity of the original PG, which was not a variable for which we could account owing to the lack of standardized clinical assessments. As such, further studies are needed to evaluate the current practice or efficacy of prophylactic immunosuppression before procedures in patients with a history of PG.
Although we identified independent predictors of recurrence risk at the procedure level, we did not find clinical factors that significantly predicted risk at the patient level. Smaller sample size on a per-patient basis (25 patients with PG recurrence vs 33 procedures complicated by PG recurrence) may have limited our ability to detect significant factors. The results of this study must be interpreted in the context of our study design. Recurrent PG is rare, thereby limiting our ability to detect differences in recurrence risk between small open, large open, and Mohs micrographic surgery/skin excision procedures. The small sample sizes may also have limited our detection of significance during examination of risk factors at the patient level as discussed earlier. Future studies should confirm our findings in larger, multicentered, prospective trials, especially evaluating whether risk factors identified in our study can be modified to decrease the risk for postsurgical recurrence or exacerbation of PG.
CONCLUSION
We conclude that there exists a small but clinically meaningful risk for postsurgical recurrence or exacerbation of PG in patients with a known history of PG, with higher risks seen with more invasive procedures and in patients with PG chronically present at time of the surgical procedure. Time elapsed between the original PG diagnosis, and surgery and prophylactic immunosuppression did not significantly affect the rate of PG recurrence. 
